Open AccessMulticenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Author(s) -
Steven R. Smith,
Neil J. Weissman,
Christen M. Anderson,
Matilde Sanchez,
Emil Chuang,
Scott Stubbe,
Harold Bays,
William Shanahan
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0909809
Subject(s) - medicine , placebo , weight loss , overweight , body mass index , obesity , anesthesia , alternative medicine , pathology
Lorcaserin is a selective serotonin 2C receptor agonist that could be useful in reducing body weight.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom